申请人:——
公开号:US20040157847A1
公开(公告)日:2004-08-12
The instant invention relates to a combination of an alpha-2-delta ligand and a PDEV inhibitor for use in therapy, particularly in the curative, prophylactic or palliative treatment of pain, particularly neuropathic pain. Particularly preferred alpha-2-delta ligands are gabapentin and pregabalin. Particularly preferred PDEV inhibitors are sildenafil, vardenafil and tadalafil.
这项瞬时发明涉及α-2-δ配体和PDEV抑制剂的组合,用于治疗,特别是在疼痛的治疗、预防或缓解中,特别是神经病性疼痛。特别偏好的α-2-δ配体是加巴喷丁和普雷加巴林。特别偏好的PDEV抑制剂是西地那非、伐地那非和他达拉非。